Castle Biosciences, Inc. (CSTL)

Castle Biosciences Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 4, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	1,156	746	581	620	1,103	1,622
Market Cap Growth	48.00%	28.53%	-6.38%	-43.76%	-32.00%	176.41%
Enterprise Value	906	493	366	368	740	1,461
Last Close Price	39.62	26.65	21.58	23.54	42.87	67.15
PE Ratio	-	40.91	-	-	-	-
PS Ratio	3.31	2.25	2.64	4.53	11.72	25.89
PB Ratio	2.47	1.64	1.48	1.55	2.68	3.90
P/TBV Ratio	3.17	2.13	2.12	2.27	3.42	3.90
P/FCF Ratio	45.57	20.43	-	-	-	317.18
P/OCF Ratio	18.72	11.51	-	-	-	164.43
EV/Sales Ratio	2.64	1.49	1.66	2.69	7.86	23.33
EV/EBITDA Ratio	115.73	20.00	-	-	-	-
EV/EBIT Ratio	-	56.90	-	-	-	-
EV/FCF Ratio	35.70	13.50	-	-	-	285.78
Debt / Equity Ratio	0.08	0.06	0.04	0.03	0.02	-
Debt / EBITDA Ratio	3.40	0.96	-	-	-	-
Debt / FCF Ratio	1.46	0.72	-	-	-	-
Asset Turnover	0.64	0.68	0.49	0.30	0.21	0.22
Inventory Turnover	9.05	7.49	7.55	10.67	7.47	5.61
Quick Ratio	6.12	6.97	5.90	7.81	13.94	20.24
Current Ratio	6.47	7.29	6.20	8.09	14.22	20.58
Return on Equity (ROE)	-2.70%	4.31%	-14.54%	-16.56%	-7.56%	-4.11%
Return on Assets (ROA)	-1.72%	1.10%	-9.43%	-12.52%	-5.56%	-1.88%
Return on Capital (ROIC)	-1.91%	1.22%	-10.37%	-13.68%	-6.00%	-2.00%
Return on Capital Employed (ROCE)	-2.90%	1.80%	-16.80%	-22.20%	-9.20%	-2.00%
Earnings Yield	-1.06%	2.44%	-9.89%	-10.82%	-2.84%	-0.63%
FCF Yield	2.19%	4.90%	-3.31%	-7.62%	-2.04%	0.32%
Buyback Yield / Dilution	-1.04%	-9.15%	-2.87%	-3.65%	-32.80%	-118.63%

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q